ClinicalTrials.gg
Not yet recruitingNCT07779681Updated Aug 21, 2026

Cold Spray and Helfer Skin Tap for Pain During Infant Vaccination

An interventional study of Cold spray and Helfer Skin Tap Technique in Procedural Pain, Vaccination Pain and Injection Pain, sponsored by Hitit University. Not yet recruiting. Open to participants aged 12 Months to 12 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-21.

Sponsored by Hitit University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
12 Months to 12 Months
Sex
All
01

Study summary

This randomized controlled experimental study aims to evaluate the effects of cold spray and the Helfer Skin Tap technique on pain levels during intramuscular pneumococcal conjugate vaccine administration in 12-month-old infants.

Vaccination is one of the most common painful procedures during infancy. Pain experienced during injections may cause distress in infants and anxiety in families. Therefore, simple, safe, non-pharmacological methods that can reduce injection-related pain are important in pediatric nursing and primary health care.

The study will be conducted at Çorum Söğütlüevler Family Health Center between March 2026 and March 2027. The study population will consist of 12-month-old infants who attend the family health center for intramuscular pneumococcal conjugate vaccination. A total of 120 infants are planned to be included in the study. Participants will be assigned to one of three groups by stratified block randomization: cold spray group, Helfer Skin Tap group, or control group. Each group will include 40 infants.

Infants in the control group will receive routine vaccination without any additional intervention. In the cold spray group, cold spray will be applied to the injection site before vaccination. In the Helfer Skin Tap group, the technique will be applied before and during the injection by gently tapping near the injection site in coordination with needle insertion.

Data will be collected using a Child Information Form, an Application Record Form, and the Face, Legs, Activity, Cry, Consolability Pain Scale (FLACC). Pain responses will be evaluated before, during, and after vaccination. Crying duration and physiological parameters such as pulse, oxygen saturation, and body temperature will also be recorded.

The findings of this study are expected to contribute to evidence-based pediatric nursing practices by identifying whether cold spray or the Helfer Skin Tap technique is effective in reducing pain during infant vaccination.

Read the detailed description

Pain during vaccination is a common source of distress for infants and concern for families. Since infants cannot verbally express pain, behavioral pain assessment tools are needed to evaluate their pain responses during painful procedures. Non-pharmacological methods that are simple, low-cost, and easy to apply may help reduce injection-related pain in primary health care settings.

This study is designed to compare two non-pharmacological pain management methods, cold spray and the Helfer Skin Tap technique, during intramuscular pneumococcal conjugate vaccine administration in 12-month-old infants. The study will be conducted in a family health center setting, where routine infant vaccinations are performed.

Eligible infants will be randomly assigned to one of three groups: a cold spray group, a Helfer Skin Tap group, or a control group. In the control group, infants will receive the routine intramuscular vaccine injection without any additional pain-reducing intervention. In the cold spray group, cold spray will be applied to the injection site before the vaccine injection. In the Helfer Skin Tap group, the researcher will apply rhythmic tapping near the injection area before and during needle insertion according to the technique.

Pain will be assessed using the Face, Legs, Activity, Cry, Consolability Pain Scale, known as the FLACC scale. Pain responses will be evaluated before, during, and after the vaccination procedure. Crying duration will also be recorded as an additional behavioral indicator of pain. Physiological parameters, including pulse, oxygen saturation, and body temperature, will be measured before and after the injection.

The study aims to determine whether cold spray or the Helfer Skin Tap technique reduces pain compared with routine vaccination practice and whether one method is more effective than the other. The results may provide evidence for pediatric nurses and primary health care professionals on the use of practical non-pharmacological pain management methods during infant vaccination.

02

Conditions studied

  • Procedural Pain
  • Vaccination Pain
  • Injection Pain

Browse trials for

Keywords

  • Cold spray
  • Helfer Skin Tap
  • Infant
  • Procedural pain
  • Vaccination
03

In context

Pain, Procedural

241 studies on the registry are indexed under Pain, Procedural; 64 are open to participants now.

This study's planned enrollment of 120 is above the median of 90 across 227 interventional studies indexed under Pain, Procedural.

Browse Pain, Procedural studies →

Lead sponsor

Hitit University is the lead sponsor of 87 studies on the registry; 29 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Months to 12 Months
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Parent or legal guardian has at least primary school education.
  • Parent or legal guardian agrees for the infant to participate in the study.
  • The infant is scheduled to receive the pneumococcal conjugate vaccine by - intramuscular injection.
  • The infant was born between 38 and 42 weeks of gestation.
  • The infant is 12 months old.
  • The infant's body weight corresponds to the 50th percentile.

Exclusion criteria

Exclusion Criteria:

  • Parent or legal guardian is illiterate.
  • The infant was born preterm or postterm.
  • The infant attends the family health center for a vaccine other than the pneumococcal conjugate vaccine.
  • The infant has a congenital anomaly, birth asphyxia, or any chronic disease.
  • The infant received an analgesic medication within at least 4 hours before vaccination.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Cold Spray Group

    Infants in this group will receive cold spray before intramuscular pneumococcal conjugate vaccination. Cold spray will be applied to the injection site from a distance of 15 cm for 5 seconds before the vaccine injection.

    Other: Cold spray

  • Experimental
    Helfer Skin Tap Group

    Infants in this group will receive the Helfer Skin Tap technique before and during intramuscular pneumococcal conjugate vaccination. The technique will be applied by tapping near the injection site in coordination with needle insertion.

    Other: Helfer Skin Tap Technique

  • No intervention
    Control Group

    Infants in this group will receive routine intramuscular pneumococcal conjugate vaccination without any additional pain-reducing intervention.

Interventions

  • OtherCold spray

    Cold spray will be applied to the injection site from a distance of 15 cm for 5 seconds before intramuscular pneumococcal conjugate vaccination.

  • OtherHelfer Skin Tap Technique

    The Helfer Skin Tap technique will be applied before and during intramuscular pneumococcal conjugate vaccination by tapping near the injection site in coordination with needle insertion.

06

What researchers measure

Primary outcomes

  1. Pain Level During Vaccination Assessed by FLACC Scale

    Pain level will be assessed using the Face, Legs, Activity, Cry, Consolability Pain Scale (FLACC). The FLACC scale evaluates five behavioral categories: face, legs, activity, cry, and consolability. Each category is scored from 0 to 2, and the total score ranges from 0 to 10. Higher scores indicate higher pain levels.

    Time frame: During intramuscular pneumococcal conjugate vaccination

Secondary outcomes

  1. Pain Level Before and After Vaccination Assessed by FLACC Scale

    Pain level will be assessed before and after vaccination using the FLACC scale. The total score ranges from 0 to 10, with higher scores indicating higher pain levels.

    Time frame: Before vaccination and immediately after vaccination

  2. Crying Duration

    Crying duration will be recorded in seconds using a stopwatch during and after the vaccination procedure. Longer crying duration indicates greater behavioral distress.

    Time frame: During vaccination and immediately after vaccination

  3. Pulse Rate Before and After Vaccination

    Pulse rate will be measured immediately before and immediately after vaccination and recorded in beats per minute (bpm).

    Time frame: Immediately before and immediately after vaccination

  4. Peripheral Oxygen Saturation Before and After Vaccination

    Peripheral oxygen saturation (SpO₂) will be measured immediately before and immediately after vaccination and recorded as a percentage (%).

    Time frame: Immediately before and immediately after vaccination

  5. Body Temperature Before and After Vaccination

    Body temperature will be measured immediately before and immediately after vaccination and recorded in degrees Celsius (°C).

    Time frame: Immediately before and immediately after vaccination

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because the study population consists of 12-month-old infants, and the collected data include sensitive health-related information. Data will be used only by the research team for the purposes of this study. Results will be reported in aggregate form without identifying individual participants.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07779681
Lead sponsor
Hitit University
Responsible party
Semra SÖNGÜT (Assistant Professor (Dr.), Hitit University) — Principal investigator
First posted
Aug 21, 2026
Start date
Sep 15, 2026 (estimated)
Primary completion
Sep 1, 2027 (estimated)
Completion
Sep 1, 2027 (estimated)
Last update
Aug 21, 2026

Study contacts

Semra söngüt, Assistant Professor (Dr.)
Contact
karacaoglu_semra@hotmail.com
+905380938989

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion